|
HSPA1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.360480E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.063300E-03 |
| Normal-vs-Stage2 |
3.775000E-03 |
| Normal-vs-Stage3 |
6.00509999999499E-05 |
| Normal-vs-Stage4 |
2.825700E-04 |
| Stage1-vs-Stage2 |
9.636600E-01 |
| Stage1-vs-Stage3 |
5.881400E-01 |
| Stage1-vs-Stage4 |
6.981600E-01 |
| Stage2-vs-Stage3 |
5.217400E-01 |
| Stage2-vs-Stage4 |
6.365000E-01 |
| Stage3-vs-Stage4 |
8.717800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.422650E-04 |
| Normal-vs-AfricanAmerican |
4.297600E-03 |
| Normal-vs-Asian |
4.788400E-01 |
| Caucasian-vs-AfricanAmerican |
6.125600E-01 |
| Caucasian-vs-Asian |
1.219770E-01 |
| AfricanAmerican-vs-Asian |
1.843390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.416080E-03 |
| Normal-vs-Female |
4.10360000002719E-06 |
| Male-vs-Female |
7.342000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.910280E-02 |
| Normal-vs-Age(41-60Yrs) |
6.4622999995656E-07 |
| Normal-vs-Age(61-80Yrs) |
2.22269999961E-07 |
| Normal-vs-Age(81-100Yrs) |
6.321800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.065800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.953400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.197200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.618200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.056600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.942000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.191710E-04 |
| Normal-vs-Grade 2 |
1.3155000000431E-06 |
| Normal-vs-Grade 3 |
6.705700E-02 |
| Normal-vs-Grade 4 |
3.63740000000057E-05 |
| Grade 1-vs-Grade 2 |
9.036200E-01 |
| Grade 1-vs-Grade 3 |
3.081200E-01 |
| Grade 1-vs-Grade 4 |
8.519200E-01 |
| Grade 2-vs-Grade 3 |
2.970600E-01 |
| Grade 2-vs-Grade 4 |
9.138400E-01 |
| Grade 3-vs-Grade 4 |
3.517800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.013900E-02 |
| Normal-vs-ccB subtype |
1.048710E-04 |
| ccA subtype-vs-ccB subtype |
8.277800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.00530000002719E-07 |
| Normal-vs-N1 |
3.324500E-03 |
| N0-vs-N1 |
6.141600E-01 |
|
|
